Issue
Alert me when new journal issues are available via or via
=free full text
Masthead page IFC Full-Text PDF (33 KB)
Introduction: Treatment of Patients With Rituximab-Refractory Indolent Non-Hodgkin’s Lymphoma Stephanie A. Gregory page S1 Full Text | Full-Text PDF (53 KB)
Historical Perspective on the Treatment Challenges of Low-Grade Non-Hodgkin’s Lymphoma Fernando Cabanillas pages S2-S6 Abstract | Full Text | Full-Text PDF (187 KB)
Current Therapeutic Approaches to Patients With Newly Diagnosed Low-Grade Non-Hodgkin’s Lymphoma Stephanie A. Gregory pages S7-S11 Abstract | Full Text | Full-Text PDF (105 KB)
Standard Approaches to Relapsed Indolent Non-Hodgkin’s Lymphoma Thomas E. Witzig pages S12-S17 Abstract | Full Text | Full-Text PDF (257 KB)
New Agents in Development for Non-Hodgkin’s Lymphoma John P. Leonard, Jia Ruan, Peter Martin, Morton Coleman, Richard R. Furman pages S18-S21 Abstract | Full Text | Full-Text PDF (97 KB)
German Experience With Bendamustine Treating Relapsed/Refractory Indolent B-Cell and Mantle Cell Lymphomas Mathias J. Rummel pages S22-S26 Abstract | Full Text | Full-Text PDF (409 KB)
Overcoming Rituximab Resistance: The US Clinical Experience With Bendamustine Jonathan W. Friedberg pages S27-S31 Abstract | Full Text | Full-Text PDF (164 KB)
Frontmatter
Table of Contents page A1 Full-Text PDF (28 KB)
Supplement Disclaimer page A2 Full-Text PDF (17 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
